Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting rare cells has large benefits

July 13, 2018

Preventing bacterial invisibility cloak

July 13, 2018

Forcing tumor cells to grow up

July 13, 2018

Phase III study of Imbruvica in treatment-naive DLBCL misses primary endpoint

July 12, 2018

Phase III maintenance trial of Ninlaro in multiple myeloma meets primary endpoint

July 12, 2018

Japanese researchers present phase II data on TAS-205 in patients with DMD

July 12, 2018

TAS-114 combined with S-1 shows preliminary efficacy in pretreated advanced gastric cancer patients

July 12, 2018

New phase III trial investigates etripamil for termination of spontaneous PSVT

July 12, 2018

Genmab and Immatics partner on next-generation bispecific cancer immunotherapies

July 12, 2018

New phase II trial explores voclosporin ophthalmic solution for dry eye syndrome

July 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...